SCIENTIFIC PROGRAM
Scientific program
The lectures
will be held in the main lecture hall located in the
central buildning of Lund University Hospital USIL.
On arrival,
you will find the registration desk outside the lecture hall
12/12 Wednesday
Opening of the meeting
Bo Ahrén,
Dean of the Medical Faculty, Lund
University
Annika Anneby-Jansson, Mayor of Lund
Session 1."Key note" presentations
Chair
persons: Karel Marsal, Per-Anders Mårdh
The role
of infection and inflammation in pre-term parturation
and fetal injury
(R.
Romero)
Gene-environment interaction and pregnancy outcomes
(M. Genc)
Cervical softening of the cervix
(G.
Ekman-Ordeberg)
Quantitative and qualitative vaginal
microflora studies: A twenty-five
year experience
(A. Onderdonk)
Session 2.
“Key note”
presentations
Chair persons: Reiner Weissenbacher,
Stefen Gerber
VVC/RVVC
(P.-A. Mårdh)
Innate
immunity in the cervicovaginal environment
(R.N.
Fichorova)
Genetic polymorphisms and individual
variations in the consequences
of genital tract infections
(S.
Witkin)
Recent developments on human
papillomavirus and genital cancers
(J.
Dillner)
13/12 Thursday
Session 1. Mucosal immunity and biochemical
defences in the LGT
Chair persons:
Steffen Thiel, Stefan Hansson
Proteomic
analysis of human vaginal fluid
(D. De Santo)
Mannan-binding lectines and other innate
immune defence mechanisms
(S. Thiel)
The role of mucins in mucosal protection
(I.
Carlstedt)
Recruitment of fibroblasts for final
cervical remodeling
(A.
Malmström)
Cervical ripening involves activation of apopptotic
encymes
(M. Sennström)
The cervical mucus plug. TIMP
activities
(M. Hein, N. Becher)
Serum protein expression profiling of
preeclampsia, using recombinant
antibody microassay
(S. Hansson)
Session 2. Cervical and vaginal
microbiology
Chair
persons: Andrew Onderdonk, Secundo Guaschino
Normal flora and lactobacilli
(G. Molin)
Abnormal vaginal flora, cervical anatomy and preterm
birth.
(G.
Donders)
Antibiotic resistance as a biological
phenomenon
(G.
Kahlmeter)
Impact of chlamydia infections on
reproductive health
(K.
Persson)
Illustration of
fallopian tubes damage caused by infection
(A. Baczynska)
Vulvovaginal candidiasis
and local immune response
(E-R.
Weissenbacher)
HSV
prophylaxis and related issues
(W. J. Ledger)
Will we get vaccines against HSV and
other genital pathogens?
(J.
Paavonen)
Feasibility of a new
self-administered cervicovaginal
lavage for diagnosing
Chlamydia
(A. Adriaanse)
14/12 Friday
Breakfast seminar
(sponsor GenProbe).
Diagnosis of
chlamydia infections - what to
believe´and how to act?
Wild-type and mutant
plasmid strains of C. trachomatis
(J. Möller)
Prevalence of a new
variant of C. trachomatis
(K. Persson)
Anonymous, patient-paid chlamydia screening by self-collected low
vaginal swab
(I. Sziller)
Session 1.
Premature birth and other adverse pregnancy
outcomes
Chair persons: Roberto Romero,
Göran Lingman
Epidemiology of premature birth
(K.
Marsal)
Cervicovaginal biomarkers to identify
women at risk
(E.R.
Norwitz)
Prevention of preterm delivery:
Contemporary options and strategies
(T.
McElrath)
Progesterone to reduce risk of preterm
delivery
(L. Rode)
Vaginal pH-measurement as preventive
strategy
(U. Hoyme)
A lunch seminar to celebrate his birthday 300 years
ago
“The genius Carl von Linné – the Man and his Achievements”
(G.
Broberg, P.-A. Mårdh)
Session 2. Cervical cancer. STD-vaccines.
Chair persons: Joakim Dillner, Mehmet Genc
Progesterone to reduce risk of preterm delivery
(U.
Gyllensten)
Screening history of women with cervical cancer
(P. Lindqvist)
Risk of cervical cancer after LEEP
conisation – A long term follow-up
(S. Mowazi)
Novel techniques in genital cancer
surgery
(P.
Kannisto)
Tumor microenvironment markers in human
cervical dysplasia
(S. Gerber)
Session 3.
Bacterial vaginosis and other topics.
Lower genital tract HIV
virology/immunology and transmission
(R.
Toumala)
Resistance
against sexual transmission of HIV
(K.
Broliden)
HIV-1 target
cells in the female genital tract
(T. Kaldensjö)
Antibiotic treatment of bacterial vaginosis for the prevention of adverse
pregnancy outcomes
(A.
Ugwumadu)
Modulation of inflammation and ischemia
in the developing brain
(D. Ley)
Incidence of bacterial vaginosis i women using
contraception
(J. Peterek)
MBL in cases with RVVC
(E. Henic)
Congenital syphilis
(C. Rodrígez-Cerdeira)
|
